SCHEMBL2600366

SCHEMBL2600366

[C-]#[N+]c1ccc2[nH]c(O)c(-c3ccc(C(=O)O)cn3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HA1 P13674 3/20 0.44
P4HTM Q9NXG6 2/20 0.44
FLT3 P36888 3/20 0.41
LDHA P00338 2/20 0.40
DYRK2 Q92630 2/20 0.37
CDK5 Q00535 2/20 0.37
HCAR3 P49019 1/20 0.37
FGFR1 P11362 1/20 0.36
FLT1 P17948 1/20 0.36
KDR P35968 1/20 0.36
PTPN11 Q06124 3/20 0.36
PTPN1 P18031 2/20 0.36
PTPN6 P29350 2/20 0.36
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
DYRK3 O43781 1/20 0.35
CDK1 P06493 1/20 0.35
CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12911323 0.79 DYRK3 (0.43) FLT3CDK5MEN1NPC1RAB9A
SCHEMBL2130483 0.79 CDK5 (0.55) P4HA1P4HTMFLT3LDHADYRK2
SCHEMBL4065919 0.78 MAPT (0.51) FLT3CDK5MEN1KMT2ACDK1
SCHEMBL4065913 0.78 MAPT (0.51) FLT3CDK5MEN1KMT2ACDK1
SCHEMBL3205187 0.70 FLT3 (0.43) FLT3DYRK2CDK5FGFR1FLT1
SCHEMBL3193236 0.67 GSK3B (0.55) FLT3CDK5FGFR1FLT1KDR
SCHEMBL68560 0.66 P4HTM (1.00) P4HA1P4HTMLDHAHCAR3NPC1
SCHEMBL29397057 0.66 P4HTM (1.00) P4HA1P4HTMLDHAHCAR3NPC1
SCHEMBL29683317 0.66 P4HTM (1.00) P4HA1P4HTMLDHAHCAR3NPC1
Potassium SCHEMBL30900922 0.64 P4HTM (0.95) P4HA1P4HTMLDHAHCAR3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120101132-A1 New Substituted Oxindole Derivative CLAESSON MARTINA (SE) 2012-04-26 US disclosed
US-20090291982-A1 New Substituted Oxindole Derivative 352 ASTRAZENECA AB (SE) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291982-A1 New Substituted Oxindole Derivative 352 PYGL, GSK3A, GSK3B P4HA1 1114/4885P4HTM 2845/4885FLT3 3231/4885
US-20120101132-A1 New Substituted Oxindole Derivative PYGL, GSK3A, GSK3B P4HA1 979/4885P4HTM 2506/4885FLT3 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.